Southwest Research Institute Aug 19 2024 Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases. Combining SwRI's 3D drug screening software tool and machine learning techniques, SwRI scientists successfully predicted the DNA binding affinity and cancer cell toxicity for a variety of relevant drug compounds under development. SwRI expanded the capabilities of its Rhodium™ drug development tool to

Tag-uri: DNA